28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          Normal platelet function is critical to blood hemostasis and maintenance of a closed circulatory system. Heightened platelet reactivity, however, is associated with cardiometabolic diseases and enhanced potential for thrombotic events. We now show gut microbes, through generation of trimethylamine N-oxide (TMAO), directly contribute to platelet hyperreactivity and enhanced thrombosis potential. Plasma TMAO levels in subjects (N>4000) independently predicted incident (3 yr) thrombosis (heart attack, stroke) risk. Direct exposure of platelets to TMAO enhanced submaximal stimulus-dependent platelet activation from multiple agonists through augmented Ca 2+ release from intracellular stores. Animal model studies employing dietary choline or TMAO, germ-free mice, and microbial transplantation, collectively confirm a role for gut microbiota and TMAO in modulating platelet hyperresponsiveness and thrombosis potential, and identify microbial taxa associated with plasma TMAO and thrombosis potential. Collectively, the present results reveal a previously unrecognized mechanistic link between specific dietary nutrients, gut microbes, platelet function, and thrombosis risk.

          Related collections

          Author and article information

          Journal
          0413066
          2830
          Cell
          Cell
          Cell
          0092-8674
          1097-4172
          26 February 2016
          10 March 2016
          24 March 2016
          24 March 2017
          : 165
          : 1
          : 111-124
          Affiliations
          [1 ]Department of Cellular & Molecular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
          [2 ]Departments of Human Genetics and Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
          [3 ]Departments of Medicine and Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599, USA
          [4 ]Department of Medicine, Medical College of Wisconsin and Blood Research Institute, Milwaukee, WI 53226, USA
          [5 ]Department of Mathematics, Cleveland State University, Cleveland, OH 44115, USA
          [6 ]Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
          Author notes
          [7 ]Address correspondence to: Stanley L. Hazen, MD PhD, Department of Cellular & Molecular Medicine, Cleveland Clinic, 9500 Euclid Avenue, NC-10, Cleveland, OH 44195; hazens@ 123456ccf.org
          [*]

          These authors contributed equally to this work

          Article
          PMC4862743 PMC4862743 4862743 nihpa759877
          10.1016/j.cell.2016.02.011
          4862743
          26972052
          dfc71dc4-7c4f-4406-92f8-e10df8fe0408
          History
          Categories
          Article

          Comments

          Comment on this article